|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase Ⅰ study显示文摘 | Bonneterre J Campone M Koralewski P | 2007 | Cancer Chemotherapy and Pharmacology2007，60，3： | 1 |
| 2 | Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial 显示文摘 | Kerbrat P Roch6 H Bonneterre J | 2007 | Br J Cancer2007，96，11： | 1 |
| 3 | ERBB2 oncogene in human breast cancer and its clinical significance显示文摘 | Revillion F Bonneterre J P | 1998 | Eur J Cancer1998，34，： | 1 |
| 4 | Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial 显示文摘 | Fargeot P Bonneterre J Roche H | 2004 | J Clin Oncol2004，22，23： | 1 |
| 5 | Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis,node-positive,early breast cancer:10-year follow-up results of the French Adjuvant Study Group 05 randomized trial显示文摘 | Bonneterre J Roche H Kerbrat P | 2005 | J Clin Oncol2005，23，12： | 1 |
| 6 | Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable,node-positive,elderly breast cancer patients:6-year follow-up results of the French adjuvant study group 08 trial显示文摘 | Fargeot P Bonneterre J Roch E H | 2004 | J Clin Oncol2004，22，23： | 1 |
| 7 | Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal,one to three node-positive,and hormone-receptor positive,early breast cancer patients:7-year follow-up results of French Adjuvant Study Group 06 randomised trial显示文摘 | Roche H Kerbrat P Bonneterre J | 2006 | Ann Oncol2006，17，8： | 1 |
| 8 | Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial显示文摘 | Bonneterre J Roche H Kerbrat P | 2005 | J Clin Oncol2005，23，12： | 1 |
| 9 | Correlation between prolactin receptor (PR L- R), estradiol(ER) and prolactin receptor (PR) in human breast cancer显示文摘 | BONNETERRE J P BEUSCART P R | 1986 | Eur J Clin Oncol1986，22，11： | 1 |
| 10 | Complete hormone blockade versus chemotherapy in premenopansal early stage breast cancer patients with positive hormone-receptor(HR + ) and 1 -3 node-positive(N + )tumor显示文摘 | Kerbrat P Bonneterre J | 2000 | Proceeding of ASCO2000，19，： | 1 |
| 11 | Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable', node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial 显示文摘 | Fargeot P Bonneterre J Roch6 H | 2004 | J Clin Oncol2004，22，23： | 1 |
| 12 | Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-years follow-up results of the French adjuvant study group 08 trial 显示文摘 | Fargeot P Bonneterre J RochO H | 2004 | J Clin Oncol2004，22，23： | 1 |
| 13 | Complete hormonal blockade versus chemotherapy in premenopausal early-stage breast cancer patients(pts)with positive hormone-receptor(HR+)and 1-3 node-positive(N+)tumor:Results of the FASG 06 trial显示文摘 | Roche′HH Kerbrat P Bonneterre J | 2000 | Proc Am Soc Clin Oncol2000，19，： | 1 |
| 14 | A phase 显示文摘 | Guastalla JP Fumoleau P | | Presented at the 18 th Annual San Antonio0，305，： | 1 |
| 15 | Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable,node-positive,elderly breast cancer patients:6-years follow-up results of the French Adjuvant Study Group 08 trial 显示文摘 | FARGEOT P BONNETERRE J ROCHE H | 2004 | J Clin Oncol2004，22，23： | 1 |
| 16 | Epirubicin increase longterm survival in adjuvant chemotherapy of patients with poorprognosis,node-positive,early breast cancer:10-year follow-up results of the French Adjuvant study Group of Randomized Trial显示文摘 | Bonneterre J Roche H Kerbrat P | 2005 | J Clin Oncol2005，23，： | 1 |
| 17 | Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer显示文摘 | BONNETERRE J PEYRAT J P BEUSCART R | 1990 | J Steroid Biochem Mol Biol1990，37，6： | 1 |
| 18 | Plasma insulin like growth factor 1 (IGF-1) concentrations in human breast cancer 显示文摘 | Peyrat J P Bonneterre J Hecquet B | 1993 | Eur J Cancer1993，29，4： | 1 |
| 19 | Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to lhree node-positive, and hormone-receptor positive, early breast cancer patients: 7 year follow-up results of French Adjuvant Study Group 06 randomised trial显示文摘 | Roche H Kerbrat P Bonneterre J | 2006 | Ann Oncol2006，17，8： | 1 |
| 20 | 10 -year update of benefit/risk ratio after adjuvant chemotherapy (CT) in node positive early breast cancer patients显示文摘 | Bonneterre J Roche H Kerbrat P | 2003 | Pro Am Soc Clin Oncol2003，21，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员